Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model

Jason T. McConville, Kirk A. Overhoff, Prapasri Sinswat, Jason M. Vaughn, Bradi L. Frei, David S. Burgess, Robert L. Talbert, Jay I. Peters, Keith P. Johnston, Robert O. Williams

Research output: Contribution to journalArticlepeer-review

63 Scopus citations


Purpose. The purpose of this study was to investigate the delivery of itraconazole (ITZ) particles to a murine lung model by nebulization. Methods. Three ITZ formulations were prepared and characterized in the dry state using contact angle, dissolution, X-ray powder diffraction, scanning electron microscopy, and Brunauer-Emmett-Teller surface area analysis. Aerodynamic particle size distributions and lung deposition studies in 14 outbred male ICR mice were performed using aqueous dispersions of all the formulations. A separate dosing uniformity study was also performed to qualify use of the chamber. Results. All formulations had an aggregated particle size of approximately 30 μm in diameter. Two formulations showed that 80% of the drug dissolved in less than 5 min. The remaining ITZ formulation had a slower dissolution and the lowest total emitted dose from the nebulizer used. High concentrations of ITZ were shown to be present in the mouse lung during the lung deposition study, up to 16.8 ± 0.13 μg/g (± SE) were achieved. Concentrations of up to 0.76 ± 0.03 μg/g (± SE) could be maintained from the single nebulized dose for at least 24 h. Conclusion. An effective method of targeted delivery of ITZ to the deep lung is presented that may be useful for the treatment and prevention of acute fungal infections.

Original languageEnglish
Pages (from-to)901-911
Number of pages11
JournalPharmaceutical Research
Issue number5
StatePublished - May 2006

Bibliographical note

Funding Information:
Acknowledgement for assistance in the in vivo study is given to Laura Najvar and John R. Graybill at The Division of Infectious Diseases at The University of Texas Health Science Center in San Antonio, Texas. The authors also acknowledge partial financial support from The Dow Chemical Company.


  • Antifungal
  • Fungal infection
  • Nanoparticle
  • Nebulization
  • Poorly water-soluble

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry
  • Pharmacology (medical)


Dive into the research topics of 'Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model'. Together they form a unique fingerprint.

Cite this